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Abstract To prospectively compare the diagnostic
performance of low-dose computed tomography coro-
nary angiography (CTCA) and cardiac magnetic reso-
nance imaging (CMR) and combinations thereof for the
diagnosis of significant coronary stenoses. Forty-three
consecutive patients with known or suspected coronary
artery disease underwent catheter coronary angiography
(CA), dual-source CTCA with prospective electrocar-
diography-gating, and cardiac CMR (1.5 Tesla). The
following tests were analyzed: (1) low-dose CTCA, (2)
adenosine stress-rest perfusion-CMR, (3) late gadolin-
ium enhancement (LGE), (4) perfusion-CMR and LGE,
(5) low-dose CTCA combined with perfusion-CMR, (5)
low-dose CTCA combined with late gadolinium-
enhancement, (6) low-dose CTCA combined with
perfusion-CMR and LGE. CA served as the standard
of reference. CA revealed[50% diameter stenoses in
68/129 (57.7%) coronary arteries in 29/43 (70%)
patients. In the patient-based analysis, sensitivity,
specificity, NPV and PPV of low-dose CTCA for the
detection of significant stenoses were 100, 92.9, 100 and
96.7%, respectively. For perfusion-CMR and LGE,
sensitivity, specificity, NPV, PPV, and accuracy were
89.7, 100, 82.4, and 100%, respectively. In the artery-
based analysis, sensitivity and NPV of low-dose CTCA
was significantly (P \ 0.05) higher than that of perfu-
sion-CMR and LGE. All combinations of low-dose
CTCA and perfusion-CMR and/or LGE did not improve
the diagnostic performance when compared to low-dose
CTCA alone. Taking CA as standard of reference, low-
dose CTCA outperforms CMR with regard to sensitivity
and NPV, whereas CMR is more specific and has a
higher PPV than low-dose CTCA.
Keywords Computed tomography  Magnetic
resonance imaging  Catheter coronary angiography 
Myocardial perfusion imaging  Coronary artery
disease
Introduction
Conventional coronary angiography (CA) represents
the clinical standard of reference for the diagnosis and
management of patients with known or suspected
coronary artery disease (CAD). Nevertheless, non-
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invasive imaging modalities including nuclear tests [1],
cardiac magnetic resonance imaging (CMR) [2], and
computed tomography coronary angiography (CTCA)
[3, 4] have challenged the role of the invasive standard.
CTCA using single-source or dual-source 64-slice
CT scanners has emerged as a robust and accurate tool
for the non-invasive diagnosis of significant coronary
stenoses. On the other hand, concerns regarding the
radiation exposure of patients undergoing CTCA have
been raised, which prompted various dose reducing
algorithms. One of the most efficient techniques for
radiation dose reduction in CTCA is prospective
electrocardiography (ECG)-gating, where radiation is
only delivered at selected time points of the cardiac
cycle [5]. First studies have shown that the low-dose
technique for CTCA is accurate for the diagnosis of
significant coronary stenoses as compared with CA
[6]. Due to maintained diagnostic accuracy combined
with the reduction of applied radiation dose, CTCA
with prospective ECG-gating has become the standard
method for CTCA in many centers [7].
CMR represents an important modality for the
indirect detection of CAD through demonstration of
myocardial perfusion defects. Stress- and rest adenosine
first pass perfusion-CMR with late gadolinium-
enhancement (LGE) allows for the detection of both
ischemic and infarcted myocardium, both indicating the
hemodynamic relevance of a coronary stenosis. Various
studies have demonstrated a high diagnostic perfor-
mance of CMR in comparison with CA [2, 8, 9].
Nevertheless, no study has—to the best of our knowl-
edge—directly compared these two non-invasive imag-
ing modalities, i.e., low-dose CTCA and CMR, with
regard to their diagnostic performance in the same
patient population.
The purpose of this study was to compare the
diagnostic performance of low-dose CTCA and perfu-
sion-CMR with LGE as well as combinations thereof
for the diagnosis of significant CAD in one patient
population taking CA as the standard of reference.
Materials and methods
Study population
We prospectively screened 55 consecutive patients
with known or suspected CAD undergoing elective
CA. Data for 39 of the patients are from an earlier
study [10]. The clinical decision to perform CA was
based on the history and the symptoms of the patient
as well as on the results from exercise stress tests.
The patients were asked to participate in this study
and written informed consent was obtained. Patients
were excluded if they had previous coronary artery
bypass graft (n = 3), impaired renal function
(n = 2), known hypersensitivity to contrast medium
used in CMR or CTCA (n = 0), heart rate [70 bpm
being not feasible for prospective ECG-gating [11]
(n = 2), contraindications for adenosine (second or
third AV-block, sick sinus syndrome, symptomatic
bradycardia, severe asthma or obstructive pulmonary
disease; n = 1) or to MR (implanted electronic
devices, metallic foreign bodies in the eye, claustro-
phobia, and others according to local regulations and
manufacturer’s recommendations; n = 4). Thus, a
total of 43 patients (9 female, mean age 63 ±
9 years, range 41–76 years) could be enrolled in this
study (Fig. 1). Patient characteristics are summarized
in Table 1. Of the 36/43 (84%) patients who had
stress-ECG testing before CA, 21/36 (58%) had signs
of ischemia, 11/36 (31%) had no signs of ischemia
and in 4/36 (11%) patients, results of stress-ECG
testing remained inconclusive. Twenty-seven of the
43 patients (63%) were receiving oral b blockers as
part of their baseline treatment.
All low-dose CTCA and CMR examinations were
performed within 1 day. The median time interval
between low-dose CTCA/CMR and CA was 20 days
(range 1–47 days).
The study protocol was approved by the local
institutional review board, all patients gave written
informed consent.
Low-dose CTCA
All CT examinations were performed on a dual-
source CT machine (Somatom Definition, Siemens
Healthcare, Forchheim, Germany) using prospective
ECG-gating. All patients received a single 2.5-mg
dose of sublingual isosorbide dinitrate (Isoket, Sch-
warz Pharma). No additional beta-blockers were
given prior to CT. Eighty to 100 ml of contrast
medium (iopromidum, Ultravist 370, Bayer Schering
Pharma, Berlin, Germany) were administered at a
flow rate of 5–6 ml s-1, followed by 50 ml of a 20%
contrast agent/80% saline solution mixture. Contrast
agent was applied using a dual-head power injector
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(Stellant, Medrad, Inianola, USA) and was controlled
by bolus-tracking using a region-of-interest in the
ascending aorta (attenuation threshold 120HU). Data
were acquired in the cranio-caudal direction during
mid-inspiration using the parameters: detector colli-
mation, 2 9 32 9 0.6 mm; slice acquisition, 2 9
64 9 0.6 mm by means of a z-flying spot; gantry
rotation time, 0.33 s. Attenuation-based tube current
modulation was used with a reference tube current–
time product set at 190 mAs per rotation. The data
acquisition window was set at 70% of the R–R
interval; the temporal resolution was 83 ms. Patients
with a body mass index (BMI) C25 kg m-2 (n = 30)
were examined with a tube voltage of 120 kV; patients
with a BMI\25 kg m-2 (n = 13) with 100 kV [11].
Low-dose CTCA images were reconstructed with a
slice thickness of 0.6 mm, using a medium smooth-
tissue convolution kernel (B30f). If the artery seg-
ment was calcified, additional reconstructions were
Fig. 1 Study workflow
Table 1 Patient demographics
Males 34 (79%)
Females 9 (21%)
Age (years) 64 ± 9
Body mass index (kg m-2) 28 ± 4
Cardiovascular risk factors
Hypertension 31 (72%)
Smoker 13 (30%)
Hyperlipidemia 30 (70%)
Family history 10 (23%)
Diabetes 8 (19%)
Symptoms
Dyspnea 23 (54%)
Atypical chest pain 5 (12%)
Typical chest pain 22 (51%)
History of myocardial infarction 9 (21%)
Previous percutaneous coronary intervention 7 (16%)
Oral b blockers part of baseline treatment 27 (63%)
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performed using a sharp-tissue convolution kernel
(B45f) to compensate for blooming artifacts. All
images were anonymized and transferred to an
external workstation (Multi-Modality Workplace,
Siemens Healthcare) for data analysis.
Low-dose CTCA data analysis
Low-dose CTCA data analysis was performed by two
independent radiologists who were both blinded to the
clinical history and to the results from any other test
(including CA and CMR). All images were evaluated
using transverse source images and multi-planar
reformations. All segments with a diameter C1 mm
at their origin were included. Vessel segments distal to
occlusions were excluded from analysis.
Coronary segments were defined according to a
scheme proposed by the American Heart Association
[12]. The intermediate artery was designated as
segment 16, if present, and together with the left
main artery was considered to belong to the left
anterior descending coronary artery (LAD).
First, both readers independently rated the image
quality of each coronary segment as being diagnostic
or non-diagnostic. Reasons for non-diagnostic image
quality were assigned to motion or stair step artifacts,
image noise, severe vessel wall calcifications, or
insufficient contrast attenuation.
Then, both readers independently evaluated all
coronary segments for the presence or absence of
significant stenoses, defined as luminal diameter
narrowing [50 and [70% respectively. Segments
containing stents were rated as either patent or non-
patent. In case of disagreement, a consensus reading
was appended 1 week after the initial read-out.
CMR
All CMR studies were performed on a 1.5-T clinical
MR system (Achieva, Philips Medical Systems, Best,
the Netherlands). Dedicated cardiac phased-array
receiver coils were used for signal reception (five
elements). All data were acquired during breath hold
in end-inspiration. The true short-axis of the left
ventricle was determined from a series of scout
images. Three representative short-axis sections were
obtained, one each in the basal, mid-ventricular, and
apical region of the left ventricle according to the
standardized 17-segment model of the American
Heart Association [13]. Pharmacological stress was
applied using adenosine which was administered
intravenously at 140 lg per kilogram of body weight
over 2.5 min under ECG, oxygen-saturation and
blood pressure monitoring. Acquisition of perfusion-
CMR images was started immediately after the
injection of gadobutrolum (Gadovist 1,0; Bayer
AG, Zurich, Switzerland). Contrast media was dosed
at 0.1 mmol per kilogram of body weight using a
power injector (MR Spectris; Medrad, Pittsburgh, Pa)
at an injection rate of 5 ml s-1, followed by a 40-ml
saline flush. Ten minutes after stress perfusion
imaging, a second bolus of 0.1 mmol gadobutrolum
was injected and rest perfusion images were obtained
with the same orientation and position as in stress-
perfusion imaging. A delay of 10 min after the stress-
perfusion examination allowed residual gadobutrolum
to be washed out from the myocardium. k–t sensitivity
encoding (SENSE) perfusion-CMR imaging was used
in combination with a saturation recovery gradient-
echo pulse sequence for both of these sequences
(repetition time/echo time, 3.1/1.1 ms; flip angle, 20;
saturation pre-pulse delay, 110 ms; partial Fourier
sampling; acquisition window, 120 ms; section thick-
ness, 10 mm; k–t factor of five with 11 k–t interleaved
training profiles; effective acceleration, 3.7; three
sections acquired sequentially during a single R–R
interval), as previously shown [14–16]. High-spatial
resolution perfusion-CMR was performed with an in-
plane resolution of 1.25 9 1.25 mm.
Ten minutes after rest perfusion, late gadolinium
enhancement (LGE) images were acquired in contin-
uous short-axis view using an inversion-recovery
gradient-recalled echo MR sequence with the fol-
lowing parameters: field of view, 350–400 mm;
repetition time/echo time, 7.4/4.3 ms; inversion time,
200–350 ms; flip angle, 20; matrix, 240 9 240; slice
thickness, 10 mm. The inversion time was optimized
individually to null the signal from normal
myocardium.
CMR Data analysis
CMR data analysis was performed on the commer-
cially available ViewForum (Philips, Best, Nether-
lands) by two different, independent radiologists who
were both blinded to the clinical history and to the
results from any other test (including CA and low-
dose CTCA). In case of disagreement between the
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readers, a consensus reading was appended after
1 week.
Perfusion-CMR as well as LGE images were
evaluated by visual analysis in each segment of a
16-segment model (17-segment American Heart
Association model [13] minus the apical segment)
and graded using a scale from 0 to 3 (0: normal, 1:
probably normal, 2: probably abnormal, 3: definitely
abnormal), as previously shown [16]. Myocardial
territories were assigned to the three major coronary
arteries according to standard definitions [13] and
were analyzed for the presence of hemodynamically
relevant CAD using three different approaches:
1) perfusion-CMR alone (PERF),
2) LGE alone, and
3) Perfusion-CMR combined with LGE according
to the following scheme: Segments were consid-
ered to have a perfusion defect if (a) late
gadolinium enhancement was present and/or (b)
a perfusion deficit was found in stress-perfusion
but not in rest-perfusion [17] (COMB).
Catheter coronary angiography
Biplane conventional CA was performed according to
standard techniques. The angiograms were evaluated
by an experienced observer who was blinded to the
results from both low-dose CTCA and CMR. The
coronary arteries were subdivided according to the
same scheme used for CTCA [12] and were quanti-
tatively assessed with the use of an automated
edge-detection system (Xcelera 1.2, Philips Medical
Systems, Best, The Netherlands). Vessel diameter
measurements were performed on two different image
planes and included the diameter of the reference
vessel (proximal and distal to the stenosis), the
minimal luminal diameter and the extent of stenosis
(defined as the diameter of the reference vessel minus
the minimal luminal diameter, divided by the refer-
ence diameter and multiplied by 100). A significant
stenosis was defined as a diameter reduction of[50%.
Statistical analysis
Quantitative data are expressed as means ± standard
deviations and categorical data are given in propor-
tions and percentages. Analysis was performed on
an intent-to-diagnose basis: Segments with a non-
diagnostic image quality at CTCA were rated as
positive for disease. Sensitivity, specificity, positive
(PPV), and negative predictive value (NPV) as well
as accuracy were obtained from contingency tables;
their 95% confidence intervals (CI) were calculated
from binomial expression. CA served as the standard
of reference.
Additionally to LGE, PERF, COMB and CTCA
alone, the following combinations were tested:
1) Low-dose CTCA in combination with perfusion-
CMR,
2) low-dose CTCA in combination with LGE, and
3) low-dose CTCA in combination with perfusion-
CMR and LGE.
For these combinations, a patient or artery was
classified as being positive for disease if any of the
tests was positive.
Agreement between methods was assessed by
using unweighted Cohen’s kappa statistics. A P-value
\0.05 was considered to indicate a significant
difference. Statistical analyses were performed using
commercially available software (SPSS, release 15.0,
Inc., Chicago, IL).
Results
Conventional coronary angiography
CA revealed [50% diameter stenoses in 114/688
segments (16.6%) corresponding to 68/129 (57.7%)
coronary arteries of 29/43 (70%) patients (Fig. 1).
Stenoses [70% diameter were depicted in 85/688
(12.4%) segments corresponding to 57/129 (44.2%)
coronary arteries in 28/43 (65%) patients.
Low-dose CTCA
During low-dose CTCA, all patients were in sinus
rhythm; the average heart rate was 61 ± 7 bpm
(range 43–69 bpm).
Of the 688 possible coronary artery segments, 111
(16.3%) segments were not present or were less than
1 mm in diameter at their origin and could therefore
not be included into analysis. Eight (1.2%) segments
were located distally to a coronary occlusion. Hence,
569/688 (82.7%) segments were included into the
analysis.
Int J Cardiovasc Imaging (2010) 26:579–590 583
123
Image quality of low-dose CTCA was diagnostic
in 561/569 (98.6%) segments in 40/43 (93%)
patients, comparable to previous reports [6, 18]. Five
segments were not assessable due to motion artifacts
and three segments were not assessable due to severe
vessel wall calcification. No stair step artifacts, image
noise, or insufficient contrast attenuation were found
as cause of non-diagnostic image quality in the
remaining 561 segments.
Low-dose CTCA revealed stenoses [50% in 127/
561 (22.6%) segments, corresponding to 72/129
(55.8%) coronary arteries in 30/43 (70%) patients
(Fig. 1). Thirty of these stenotic arteries were located
in the LAD, 20 in the LCX, and 22 in the RCA.
Stenoses of [70% were depicted in 86/561 (15.3%)
segments, corresponding to 62/129 (48.1%) coronary
arteries in 29/43 (67%) patients.
CMR
After adenosine-injection, no adverse effects leading
to discontinuation of CMR were observed. Image
quality of perfusion-CMR and LGE images was
diagnostic in all myocardial segments of all patients.
Myocardial defects were found in 140/688 (20.3%)
segments corresponding to the territories of 57/129
(44.2%) coronary arteries in 26/43 (61%) patients
(Fig. 1). Nineteen of the arteries positive for CAD
were assigned to the LAD, 16 to the LCX, and 22 to
the RCA.
Diagnostic performance
Low-dose CTCA
Sensitivity, specificity, NPV, PPV, and accuracy of
low-dose CTCA for the detection of coronary stenoses
in the artery-based analysis were 95.6, 88.5, 94.7,
90.3, and 92.2%, respectively, and 100, 92.9, 100,
96.7, and 97.7%, respectively, in the patient-based
analysis (Table 2) when taking \50% stenosis as
cutoff value. One false-positive rating occurred in a
patient having a less than 50% stenosis according to
CA in the proximal LAD. At low-dose CTCA, this
stenosis was judged to be significant (Fig. 2). When
the threshold is increased to [70% for significant
stenosis, the values for diagnostic accuracy of CTCA
slightly decrease as now two patients are overesti-
mated by low-dose CTCA as shown in Table 3.
Overall agreement between low-dose CTCA and
CA for the detection of coronary stenoses was 92.2%
(kappa 0.8) and 97.7% (kappa 0.95), respectively, in
the artery- and patient-based analysis.
CMR
The sensitivity, specificity, NPV, PPV, and accuracy
of perfusion-CMR combined with LGE images in the
artery-based analysis was 69.1, 83.6, 70.8, 82.5, and
76%, respectively, and 89.7, 100, 82.4, 100, and 93%,
respectively, in the patient-based analysis (Table 2).
Adding LGE to perfusion-CMR showed an increase
in sensitivity and NPV and was based on the
detection of significant CAD in two patients with
no perfusion deficits but myocardial infarction
(Fig. 3). When the threshold for significant stenosis
is raised to \70%, the sensitivity and NPV of CMR
slightly increases as the specificity and PPV slightly
decrease as shown in Table 3.
Overall agreement between perfusion-CMR com-
bined with LGE images and CA was 76% (kappa
0.52) and 93% (kappa 0.85), respectively, in the
artery- and patient-based analysis.
Combination of low-dose CTCA and CMR
Combinations of low-dose CTCA and perfusion-
CMR and/or LGE revealed minor increases in
sensitivity and NPV as compared to low-dose CTCA
alone. Values for specificity, PPV and accuracy
decreased at the same time. None of the changes in
diagnostic performance as compared to that of low-
dose CTCA alone was significant (see Tables 2, 3).
Discussion
This study is the first to directly compare the
diagnostic performance of low-dose CTCA and
CMR for the detection of significant CAD in one
patient population. Taking CA as the standard of
reference, low-dose CTCA outperformed CMR with
regard to sensitivity and NPV. On the other hand,
CMR was more specific and had a higher PPV than
did low-dose CTCA in a patient-based analysis. Any
combination of the two non-invasive imaging tests
did not improve the diagnostic performance as
compared to that of low-dose CTCA alone.
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Low-dose CTCA
CTCA using prospective ECG-gating was recently
shown to be feasible in selected patients having a
regular heart rate yielding radiation dose values as low
as 1–4 mSv [6]. The diagnostic performance of CTCA
known from previous single-source and dual-source
64-slice CT studies conducted in the retrospective
ECG-gating mode [3, 4] could be maintained using the
low-dose technique. The comparable diagnostic accu-
racy of CTCA as compared to CA has been shown in
previous studies and could again be confirmed by our
results [3, 6, 19, 20]. The most important clinical value
of CTCA derives from its high sensitivity and NPV,
allowing to reliably ruling-out CAD with the non-
invasive test. On the other hand, specificity and PPV
of CTCA are known to be lower, usually because of
false-positive ratings occurring in the presence of
severe vessel wall calcifications. These performance
characteristics of CTCA could be confirmed in this
study. In one patient, a heavily calcified stenosis at the
origin of the LAD was overestimated with low-dose
CTCA as being significant, whereas CA only showed
a stenosis less than 50%. A total of two patients were
overestimated with low-dose CTCA when taking
[70% as the cutoff value for significant stenosis.
Overestimation of stenosis grading must not be
considered a specific drawback of prospective ECG-
gating itself [21], but similarly occurs with retrospec-
tive ECG-gating in the helical mode [3, 4].
CMR
First pass perfusion under rest and adenosine-induced
stress is a widely accepted CMR-technique for the
detection of reduced myocardial blood flow. In
addition to perfusion-CMR, LGE images are also
acquired and help in the detection and quantification
of infarcted myocardium. Thus, it is the rule to
combine these two CMR-techniques for improving
the non-invasive detection of CAD [17]. It is
important, however, to recognize that LGE can be
caused by other diseases apart from CAD, such as
hypertrophic or dilated cardiomyopathy [22, 23].
Also, unrecognized myocardial infarction as depicted
by LGE can occur as the result of a spontaneous
thrombolysis and recannulation of an acute coronary
lesion [24]. On the other hand, coronary stenosis in
patients with CAD not necessarily leads to scarifica-
tion of the myocardium, which is underlined by the
low sensitivity of LGE imaging in our patient cohort.
Our study results regarding perfusion-CMR with
LGE are in line with the data reported in the literature
[25]. Most importantly, CMR showed an excellent
specificity and PPV for the diagnosis of hemodynam-
ically relevant CAD. On the other hand, a relatively
low sensitivity and NPV was found, indicating the
above stated fact that not every ‘‘morphologic’’
stenosis[50% irrevocably leads to a perfusion defect
in the corresponding myocardial segment. When
raising the threshold for significant stenosis to
[70%, patients with coronary artery stenosis between
51 and 70% with ischemia as depicted on CMR are
now rated to be false-positive. Therefore, the slight
increase in sensitivity and NPV of CMR is accompa-
nied by a slight decrease in specificity and PPV.
Combining low-dose CTCA and CMR
It is known that the morphological assessment of a
coronary lesion with CA or CTCA does not neces-
sarily correlate with the impairment in myocardial
Fig. 2 76-year-old male with clinical suspicion of CAD. CA
revealed a non-significant stenosis at the origin of the LAD (a,
arrow). At low-dose CTCA, this stenosis was judged as being
significant (b, arrowhead). Perfusion-CMR showed no perfu-
sion deficit (c, adenosine stress). No late gadolinium enhance-
ment was found (not shown)
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blood flow caused by the stenosis. Owing to the
performance characteristics of low-dose CTCA,
patients with no coronary stenoses can be safely
discharged without further testing. On the other hand,
patients with obstructive lesions at CTCA should
undergo a functional test such as CMR for evaluating
the hemodynamic relevance of the stenosis. CMR
might qualify as a second line imaging technique in
patients with non diagnostic coronary artery segments
on low-dose CTCA. The three patients in our study
which had one or more non-diagnostic segments all
had other significant stenoses in different segments of
the same vessel, therefore not influencing the results
of diagnostic accuracy. In certain cases, where low-
dose CTCA is not diagnostic, however, CMR can
help to confirm or exclude CAD.
Thus, we did expect that the strengths and weak-
nesses of the two imaging tests would counterbalance
each other. However, no combination between low-
dose CTCA and perfusion-CMR and/or LGE did lead
to a relevant increase in the diagnostic performance
when compared to CTCA alone. This study result
could be caused by the known variability in the
coronary artery blood supply to myocardial segments
[26]. Another, more probable explanation is the purely
morphoanatomic nature of our reference standard.
Limitations
The number of included patients was relatively low.
Our patients were referred for CA and as such
represent a selected patient population. The cohort
was characterised by a relatively high prevalence of
CAD that may have resulted in an overestimation of
the ability of DSCT to detect and to rule out stenoses
[27]. Thus, our study results may not be transferred to
a more unselected group of patients. Further studies
are needed to confirm our results in a larger and more
homogeneous patient cohort. Secondly, as mentioned
above, we compared a functional imaging test taking
a morphological test as the reference standard
without additional functional assessment such as
fractional flow reserve. This may underestimate the
true diagnostic performance of CMR for the diagno-
sis of hemodynamically relevant CAD. On the other
Fig. 3 60-year-old male with clinical suspicion of CAD. CA
showed a significant stenosis of the distal LCX (a, arrowheads)
and occlusion of the first posterolateral branch (a, arrow).
Low-dose CTCA confirmed the significant stenosis (b,
arrowheads) and occlusion (b, arrow). Stress-(c) and rest-
perfusion-CMR (d) revealed no perfusion deficit. Late gado-
linium enhancement was found in anterolateral and partially in
inferolateral myocardial segments, corresponding to the LCX
territory (arrowheads, e)
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hand, a comparison with CA is the standard in the
majority of studies assessing the value of non-
invasive cardiac testing.
Finally, CMR images were analyzed purely visu-
ally using a previously described algorithm [2, 15–
17]. No semi-quantitative analysis of perfusion-CMR
was performed. However, most studies investigating
the diagnostic accuracy of CMR for the detection of
CAD utilize purely visual evaluation [2, 15–17, 28]
and the majority of centers continue to use visual
analysis for the assessment of clinical myocardial
perfusion scans [29]. Comparing the rest and stress
scans together on a viewing platform allows the
recognition of perfusion defects and discrimination
from artifacts, as previously shown [30]. Recognition
of artifacts is critical for accurate analysis of scans
because artifacts with rapid image acquisition usually
manifest themselves as dark subendocardial rims and
may mimic perfusion defects.
Conclusion
Compared to CA, low-dose CTCA outperforms CMR
with regard to sensitivity and NPV, whereas CMR is
more specific and has a higher PPV than low-dose
CTCA. Combined approaches of low-dose CTCA
and CMR did not improve the performance of CTCA
alone, most probably because of the use of a purely
morphological imaging test as the standard of
reference.
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